News - Ultibro Breezhaler

Filter

Current filters:

Ultibro Breezhaler

Popular Filters

Minor added benefit of Novartis’ Ultibro/Xoterna Breezhaler in COPD, says IQWiG

Minor added benefit of Novartis’ Ultibro/Xoterna Breezhaler in COPD, says IQWiG

19-02-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

GermanyNorthern EuropeNovartisPharmaceuticalPricingRegulationRespiratory and PulmonaryUltibro BreezhalerXoterna Breezhaler

Novartis gains EU and Japan approval for COPD treatments

Novartis gains EU and Japan approval for COPD treatments

24-09-2013

Swiss drug major Novartis has received approval from the European Commission for once-daily Ultibro Breezhaler…

EuropeNovartisPharmaceuticalRegulationRespiratory and PulmonaryUltibro Breezhaler

Further evidence of Ultibro Breezhaler efficacy showcased at ERS meeting

09-09-2013

Swiss drug major Novartis (NOVN: VX) released date data from new analyses for once-daily Ultibro Breezhaler…

NovartisPharmaceuticalResearchRespiratory and PulmonarySeebri BreezhalerUltibro BreezhalerVectura

Vectura foresees important catalysts in second half

13-08-2013

Shares of UK-based developer of inhaled therapies Vectura (LSE: VEC) rose 1.6% to 96 pence in mid-morning…

EuropeFinancialPharmaceuticalRespiratory and PulmonarySeebri BreezhalerUltibro BreezhalerVectura

Two CHMP positives for Novartis

29-07-2013

There was a flow of positive news from the European Medicines Agency on Friday (July 26) for Swiss drug…

Anti-Arthritics/RheumaticsEuropeIlarisNovartisPharmaceuticalRegulationRespiratory and PulmonaryUltibro BreezhalerVectura

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top